Keyword

brigatinib

Description: Brigatinib is an anticancer drug that inhibits anaplastic lymphoma kinase and is used to treat certain forms of non-small cell lung cancer.
Wikidata ID: wiki/Q27456393
OpenAlex ID: keywords/brigatinib
2018 · D. Ross Camidge, Hye Ryun Kim, et al. · New England Journal of Medicine · 1,087
2016 · Wei-Sheng Huang, Shuangying Liu, et al. · Journal of Medicinal Chemistry · 448
2021 · Nasser H. Hanna, Andrew G. Robinson, et al. · Journal of Clinical Oncology · 333
2016 · Jingjing Wu, John Savooji, et al. · Journal of Hematology & Oncology · 176
2015 · Ivana Sullivan, David Planchard · Therapeutic Advances in Medical Oncology · 158
2017 · Anthony Markham · Drugs · 150
2019 · Xiaotian Kong, Peichen Pan, et al. · Journal of Medicinal Chemistry · 137
2023 · Aditya Shreenivas, Filip Janku, et al. · npj Precision Oncology · 132
2022 · Navneet Singh, Sarah Temin, et al. · Journal of Clinical Oncology · 121
2017 · Assunta Sgambato, Francesca Casaluce, et al. · Expert Review of Anticancer Therapy · 98
2022 · Ling Peng, Liping Zhu, et al. · Frontiers in Oncology · 89
2020 · Ning Sun, Chaowei Ren, et al. · European Journal of Medicinal Chemistry · 88
2018 · Jessica J. Lin, Viola W. Zhu, et al. · Journal of Thoracic Oncology · 86
2022 · Laird B Cameron, Nadia Hitchen, et al. · Cochrane Database of Systematic Reviews · 81
2024 · Scott R. Plotkin, Kaleb H. Yohay, et al. · New England Journal of Medicine · 80
Works count: 1,166
Citation count: 13,490
Year
Topic
Type